These criteria are based on the assessment of whether opioid use causes significant impairment in physical and social functioning, as well as aspects of craving and unsuccessful efforts to reduce or control use. The presentation of 2 or more of the 11 DSM-5 criteria for OUD within ...
Opioid use disorder (OUD) is a chronic, relapsing disease. Genetic variability, dysregulated stress system response, and history of opioid experimentation or escalating exposure all contribute to the likelihood of developing OUD, which produces complex brain changes that make it difficult to stop ...
Medications for maintenance treatment of opioid use disorder in adolescents: a narrative review and assessment of clinical benefits and potential risks. J Stud Alcohol Drugs. 2019;80(4):393-402. doi:10.15288/jsad.2019.80.393 PubMedGoogle ScholarCrossref 46. Mauro PM, Samples H...
comparisonDenmarkFinlandIcelandNorwayopioid use disorderSwedenAims: Outcomes in opioid use disorder (OUD) in Nordic countries have improved with integrated treatment and harm-reduction programmes. Approaches and the standard of care are different across the region. Evidence of treatment needs and current ...
According to the DSM, the essential feature of a Opioid-Use Disorder is a problematic pattern of opioid use leading to clinically significant impairment or distress, as manifested by at least two of the following, occurring within a 12-month period (Diagnostic and Statistical Manual of ...
Despite the large toll of opioid use disorder (OUD), genome-wide association studies (GWAS) of OUD to date have yielded few susceptibility loci. We performed a large-scale GWAS of OUD in individuals of European (EUR) and African (AFR) ancestry, optimizin
The Intake 1 interview addressed sociodemographic background, education, alcohol and drug use history, illegal involvement, and employment. Intake 2 contained assessment modules based on standard clinical instruments such as the Diagnostic Interview Schedule (Robins, Helzer, Croughan, & Ratcliff, 1981),...
Incarcerated populations experience an elevated prevalence of opioid use disorder (OUD). Federal correctional institutions in Canada have increasingly treated OUD among correctional populations via opioid agonist treatment (OAT) – an evidence based phar
Has the treatment gap for opioid use disorder narrowed in the U.S.?: a yearly assessment from 2010 to 2019. Int J Drug Policy. 2022;110:103786. doi:10.1016/j.drugpo.2022.103786PubMedGoogle ScholarCrossref 17. Ray JM, Ahmed OM, Solad Y, et al. Computerized clinical ...
Use With Persistent Use JAMA Network Open Research June 3, 2021 Mindfulness Training vs Recovery Support During Buprenorphine Treatment JAMA Network Open Research January 21, 2025 Medication for Opioid Use Disorder in Federally Qualified Health Centers JAMA Network Open Research January 16, 2025 Select ...